vs
爱德华生命科学（EW）与FLOWERS FOODS INC（FLO）财务数据对比。点击上方公司名可切换其他公司
爱德华生命科学的季度营收约是FLOWERS FOODS INC的1.3倍（$1.6B vs $1.2B），爱德华生命科学同比增速更快（16.7% vs -75.8%），过去两年爱德华生命科学的营收复合增速更高（9.7% vs -11.6%）
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
花氏食品总部位于美国佐治亚州托马斯维尔，是美国知名的包装烘焙食品生产商与销售商。公司在全美19个州运营44家面包工厂，生产面包、餐包、小食蛋糕、点心、玉米饼等多元化产品，截至2013年2月已成长为美国第二大烘焙企业。
EW vs FLO — 直观对比
营收规模更大
EW
是对方的1.3倍
$1.2B
营收增速更快
EW
高出92.5%
-75.8%
两年增速更快
EW
近两年复合增速
-11.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.2B |
| 净利润 | $380.7M | — |
| 毛利率 | 78.0% | — |
| 营业利润率 | 1.8% | — |
| 净利率 | 23.1% | — |
| 营收同比 | 16.7% | -75.8% |
| 净利润同比 | 6.8% | — |
| 每股收益（稀释后） | $0.66 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWFLO
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.2B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.5B | $1.6B | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | $1.2B | ||
| Q3 24 | $1.4B | $1.2B | ||
| Q2 24 | $1.4B | $1.6B |
净利润EWFLO
| Q1 26 | $380.7M | — | ||
| Q4 25 | $91.2M | $39.5M | ||
| Q3 25 | $291.1M | $58.4M | ||
| Q2 25 | $333.2M | $53.0M | ||
| Q1 25 | $358.0M | — | ||
| Q4 24 | $385.6M | $65.0M | ||
| Q3 24 | $3.1B | $67.0M | ||
| Q2 24 | $366.3M | $73.0M |
毛利率EWFLO
| Q1 26 | 78.0% | — | ||
| Q4 25 | 78.1% | — | ||
| Q3 25 | 77.8% | — | ||
| Q2 25 | 77.5% | — | ||
| Q1 25 | 78.7% | — | ||
| Q4 24 | 78.9% | — | ||
| Q3 24 | 80.6% | — | ||
| Q2 24 | 79.9% | — |
营业利润率EWFLO
| Q1 26 | 1.8% | — | ||
| Q4 25 | 9.6% | 5.4% | ||
| Q3 25 | 19.8% | 7.5% | ||
| Q2 25 | 26.8% | 5.5% | ||
| Q1 25 | 27.9% | — | ||
| Q4 24 | 22.6% | 7.6% | ||
| Q3 24 | 25.9% | 7.8% | ||
| Q2 24 | 26.8% | 6.4% |
净利率EWFLO
| Q1 26 | 23.1% | — | ||
| Q4 25 | 5.8% | 3.2% | ||
| Q3 25 | 18.7% | 4.7% | ||
| Q2 25 | 21.7% | 3.4% | ||
| Q1 25 | 25.3% | — | ||
| Q4 24 | 27.8% | 5.5% | ||
| Q3 24 | 226.7% | 5.5% | ||
| Q2 24 | 26.7% | 4.6% |
每股收益（稀释后）EWFLO
| Q1 26 | $0.66 | — | ||
| Q4 25 | $0.16 | $0.19 | ||
| Q3 25 | $0.50 | $0.28 | ||
| Q2 25 | $0.56 | $0.25 | ||
| Q1 25 | $0.61 | — | ||
| Q4 24 | $0.65 | $0.31 | ||
| Q3 24 | $5.13 | $0.32 | ||
| Q2 24 | $0.61 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $12.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | — |
| 总资产 | — | $4.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EWFLO
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $16.7M | ||
| Q3 25 | $3.8B | $11.0M | ||
| Q2 25 | $4.1B | $7.3M | ||
| Q1 25 | $3.9B | — | ||
| Q4 24 | $4.0B | $15.0M | ||
| Q3 24 | $4.4B | $6.9M | ||
| Q2 24 | $2.0B | $15.8M |
总债务EWFLO
| Q1 26 | — | — | ||
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.0B |
股东权益EWFLO
| Q1 26 | — | — | ||
| Q4 25 | $10.3B | $1.4B | ||
| Q3 25 | $10.2B | $1.4B | ||
| Q2 25 | $10.5B | $1.4B | ||
| Q1 25 | $10.1B | — | ||
| Q4 24 | $10.0B | $1.4B | ||
| Q3 24 | $9.5B | $1.4B | ||
| Q2 24 | $7.4B | $1.4B |
总资产EWFLO
| Q1 26 | — | — | ||
| Q4 25 | $13.7B | $4.3B | ||
| Q3 25 | $13.3B | $4.3B | ||
| Q2 25 | $13.5B | $4.3B | ||
| Q1 25 | $13.0B | — | ||
| Q4 24 | $13.1B | $3.4B | ||
| Q3 24 | $13.0B | $3.4B | ||
| Q2 24 | $10.1B | $3.4B |
负债/权益比EWFLO
| Q1 26 | — | — | ||
| Q4 25 | — | 1.25× | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 1.26× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.75× | ||
| Q3 24 | — | 0.77× | ||
| Q2 24 | — | 0.76× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $125.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流EWFLO
| Q1 26 | — | — | ||
| Q4 25 | $450.9M | $54.4M | ||
| Q3 25 | $573.7M | $130.8M | ||
| Q2 25 | $290.2M | $135.6M | ||
| Q1 25 | $280.4M | — | ||
| Q4 24 | $-127.5M | $113.9M | ||
| Q3 24 | $351.8M | $63.3M | ||
| Q2 24 | $371.5M | $105.1M |
自由现金流EWFLO
| Q1 26 | — | — | ||
| Q4 25 | $353.5M | $30.4M | ||
| Q3 25 | $516.2M | $100.0M | ||
| Q2 25 | $240.9M | $110.1M | ||
| Q1 25 | $224.4M | — | ||
| Q4 24 | $-177.3M | $88.6M | ||
| Q3 24 | $299.9M | $35.4M | ||
| Q2 24 | $286.1M | $71.8M |
自由现金流率EWFLO
| Q1 26 | — | — | ||
| Q4 25 | 22.5% | 2.5% | ||
| Q3 25 | 33.2% | 8.0% | ||
| Q2 25 | 15.7% | 7.1% | ||
| Q1 25 | 15.9% | — | ||
| Q4 24 | -12.8% | 7.4% | ||
| Q3 24 | 22.1% | 2.9% | ||
| Q2 24 | 20.9% | 4.6% |
资本支出强度EWFLO
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 2.0% | ||
| Q3 25 | 3.7% | 2.5% | ||
| Q2 25 | 3.2% | 1.6% | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 3.6% | 2.1% | ||
| Q3 24 | 3.8% | 2.3% | ||
| Q2 24 | 6.2% | 2.1% |
现金转化率EWFLO
| Q1 26 | — | — | ||
| Q4 25 | 4.94× | 1.38× | ||
| Q3 25 | 1.97× | 2.24× | ||
| Q2 25 | 0.87× | 2.56× | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | -0.33× | 1.75× | ||
| Q3 24 | 0.11× | 0.94× | ||
| Q2 24 | 1.01× | 1.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
